1-3 of 3
P Simon
Close
Sort by
Journal Articles

Efficacy and Tolerability of Lenalidomide/Dexamethasone in Intensively Pretreated Myeloma Patients: Experiences from the German Named Patient Program.

Ulrike Klein, MD, Igor W. Blau, MD, Monika Engelhardt, Jan P. Simon, MD, Hartmut Goldschmidt, Hermann Einsele, Stefan Knop, MD
Journal: Blood
Blood (2007) 110 (11): 4834.
https://doi.org/10.1182/blood.V110.11.4834.4834
Published: 2007
Journal Articles

Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.

Christoph von Schilling, MD, Kathleen Schwarz, MD, Georg Hess, MD., Ph.D., Andreas Viardot, MD, Michael Sandherr, MD, Stefan Krause, MD., Ph.D., Jan P. Simon, MD, Ph.D., Nadine Roethling, Christian Peschel, MD, Ph.D., Markus Schwaiger, MD, Ph.D., Klemens Scheidhauer, MD, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3426.
https://doi.org/10.1182/blood.V110.11.3426.3426
Published: 2007
Journal Articles

The human cardiac mast cell: localization, isolation, phenotype, and functional characterization

WR Sperr, HC Bankl, G Mundigler, G Klappacher, K Grossschmidt, H Agis, P Simon, P Laufer, M Imhof, T Radaszkiewicz
Journal: Blood
Blood (1994) 84 (11): 3876–3884.
https://doi.org/10.1182/blood.V84.11.3876.bloodjournal84113876
Published: 1994